Table 1.
Overrepresented functional classes among genes significantly regulated by MA in MADR selected lines.
Gene | Name | Apop | Immu | Cyto | Toll | Erbb | Oxid | Ster | MAHDR | MALDR | Saline |
---|---|---|---|---|---|---|---|---|---|---|---|
Clcf1 | Cardiotrophin-like cytokine factor 1 | • | • | ↓ | L | ||||||
Ripk1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | • | • | ↓ | |||||||
Lta | Lymphotoxin A (aka TNF-beta) | • | • | • | ↓ | ||||||
Pawr | PRKC, apoptosis, WT1, regulator | • | • | ↓ | |||||||
Hspa5 | Heat shock 70kD protein 5 | • | ↑ | ↑ | |||||||
Il6 | Interleukin 6 | • | • | • | • | • | ↓ | ||||
Atf5 | Activating transcription factor 5 | • | ↓ | ||||||||
Casp8 | Caspase 8 | • | • | ↓ | |||||||
Il2rb | Interleukin 2 receptor, beta chain | • | • | ↓ | |||||||
Gzmb | Granzyme B | • | ↓ | ||||||||
Fas | Fas (TNF receptor superfamily member 6) | • | • | • | ↓ | ||||||
Atm | Ataxia telangiectasia mutated homolog | • | ↓ | ||||||||
Bcl2 | B-cell leukemia/lymphoma 2 | • | ↓ | L | |||||||
H2-Ea | Histocompatibility 2, class II antigen E alpha | • | ↓ | L | |||||||
Tgfb1 | Transforming growth factor, beta 1 | • | • | ↓ | |||||||
Ccl2 | Chemokine (C-C motif) ligand 2 | • | • | ↓ | |||||||
Ccl3 | Chemokine (C-C motif) ligand 3 (aka MIP-1alpha) | • | • | • | ↓ | ||||||
Nfkb2 | Nuclear factor of kappa enhancer in B-cells (p52/p100) | • | • | ↑ | ↓ | ||||||
Il1rn | Interleukin 1 receptor antagonist | • | ↓ | ||||||||
Egfr | Epidermal growth factor receptor | • | • | ↑ | |||||||
Mapk3 | Mitogen-activated protein kinase 3 (aka Erk-1) | • | • | ↓ | |||||||
Fos | FBJ osteosarcoma oncogene (aka AP-1) | • | ↑ | ||||||||
Esr1 | Estrogen receptor 1 (alpha) | • | • | ↓ | |||||||
Erbb3 | V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 | • | ↑ | ||||||||
Ptgs2 | Prostaglandin-endoperoxide synthase 2 (aka Cox-2) | • | ↓ | ||||||||
Atp5c1 | ATP synthase, H+ transporting, mitochondrial F1 complex | • | ↓ | ||||||||
Ndufs8 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 | • | ↓ | ||||||||
Uqcrc2 | Ubiquinol cytochrome c reductase core protein 2 | • | ↓ | ||||||||
Atp5g3 | ATP synthase, H+ transporting, mitochondrial F0 complex | • | ↓ | ||||||||
Atp5j | ATP synthase, H+ transporting, mitochondrial F0 complex | • | L | ||||||||
Esr2 | Estrogen receptor 2 (beta) | • | ↑ | ||||||||
Thra | Thyroid hormone receptor alpha | • | ↓ | ||||||||
Ar | Androgen receptor | • | ↑ |
Arrows in the columns labeled ‘MAHDR’ and ‘MALDR’ indicate the direction of regulation of each gene in response to MA. The column labeled ‘Saline’ indicates which line, if any, showed higher expression of the gene in a drug-naïve state (H = MAHDR; L = MALDR). Overrepresented functional groups were identified using the DAVID Bioinformatics Resources (david.niaid.nih.gov; Huang et al., 2007). The 384 genes represented on the qPCR array were used as the background gene list for pathway analysis. Significance levels for each class: Apoptosis (Apop) p = 0.04; Immune response (Immu) p = 0.0013; Cytokine receptor interaction (Cyto) p = 0.0011; Toll-like receptor signaling pathway (Toll) p = 0.019; ERBB2 signaling pathway p = 0.061; Oxidative phosphorylation (Oxid) p = 0.0097; Steroid hormone receptors (Ster) p = 0.018.